MeDiC | Metabolic Disorders and Complications Program
Leadership and Management
The Metabolic Disorders and Complications Program (MeDiC) is managed by a Program Management Committee that meets at least four times per year and is responsible for developing a strategic research plan for our group of investigators, fostering collaboration, and enhancing funding success as well as organizing scientific activities for staff and trainees. The current Program Management Committee members are:
Dr. Simon Wing, Program Leader
Sergio Burgos, PhD, Associate Program Leader
Christian Rocheleau, PhD, Associate Program Leader
Dr. Ruth Sapir-Pichhadze, Associate Program Leader
Lenka Schorova, M.Sc., PhD, Program Manager
Khiran Arumugan, Student Representative, Centre for Outcomes Research and Evaluation (CORE)
Tatsuya Kato and Hannah Swick, Student Representatives, Centre for Translational Biology (CTB)
| Program leaders and manager | ||
 Simon Wing, MD, is a Professor of Medicine at McGill University and physician in the Division of Endocrinology and Metabolism at the McGill University Health Centre. His research focuses on the physiological functions of the ubiquitin proteasome system, which degrades the majority of cell proteins in a highly regulated and precise fashion. His work has identified genes in this system which play important roles in the protein degradation that leads to muscle wasting, a complication in cancer and many other chronic diseases. He has also identified genes in the ubiquitin system that are essential for sperm development and function and appear to be involved in male infertility. His work has been recognized by election to the American Society for Clinical Investigation and is presently funded by the Canadian Institutes of Health Research and the Canadian Cancer Society Research Institute. Dr. Wing has served in other leadership roles, including directing the McGill Clinical Investigator Program and the Division of Adult Endocrinology and Metabolism at McGill University and the McGill University Health Centre. He presently chairs the Research Council of the Research Institute of the McGill University Health Centre. Lenka Schorova, M.Sc., PhD, completed her graduate studies at Trinity College Dublin in Ireland and obtained her doctorate in molecular and cellular interactions and neuroscience from the Université Côte d'Azur in 2018. She then completed postdoctoral training in neurodegeneration. She brings more than nine years of experience to management of the MeDiC Program, with her excellent communication and leadership skills. | ||